Reason for request
Re-assessment of the Actual Benefit
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicinal product ROHYPNOL is insufficient in the treatment of "severe sleep disorders in the following cases: occasional insomnia, transient insomnia". |
Therapeutic use
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
f9fLCD2XcrJWJTTk
